Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | APEX1 | P27695 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | CNR2 | P34972 | 7/20 | 0.37 |
| ▸ | CNR1 | P21554 | 6/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | SNCA | P37840 | 2/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESRRG | P62508 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL124487 | 0.88 | THRB (0.50) | THRBMEN1KMT2ATDP1APEX1 | |
| SCHEMBL20740546 | 0.86 | THRB (0.48) | THRBMEN1KMT2ATDP1APEX1 | |
| SCHEMBL341270 | 0.86 | THRB (0.45) | THRBMEN1KMT2ATDP1CNR2 | |
| SCHEMBL29413087 | 0.85 | THRB (0.50) | THRBMEN1KMT2ATDP1APEX1 | |
| SCHEMBL2859639 | 0.84 | THRB (0.53) | THRBMEN1KMT2ATDP1APEX1 | |
| SCHEMBL2868709 | 0.84 | THRB (0.53) | THRBMEN1KMT2ATDP1APEX1 | |
| SCHEMBL9106113 | 0.83 | THRB (0.53) | THRBMEN1KMT2ATDP1APEX1 | |
| SCHEMBL2859161 | 0.82 | THRB (0.56) | THRBMEN1KMT2ATDP1APEX1 | |
| Ammonia Solution, Strong SCHEMBL1462578 | 0.82 | THRB (0.49) | THRBMEN1KMT2ATDP1APEX1 | |
| SCHEMBL9108467 | 0.81 | THRB (0.51) | THRBMEN1KMT2ATDP1APEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6984303-B2 | Electrochemical production of dyes using graphite felt electrodes | NOVEON IP HOLDINGS CORP. (US) | 2006-01-10 | — | — | US | claimed |
| US-20040163968-A1 | Electrochemical production of dyes using graphite felt electrodes | EMERALD HILTON DAVIS, LLC | 2004-08-26 | — | — | US | claimed |
| US-20260063622-A1 | METHOD, SYSTEM, AND DEVICE FOR ANALYZING CELLULAR PROPERTIES WITH MACHINE LEARNING TO IDENTIFY STATES OF SENESCENCE | UNIV NEW YORK (US) | 2026-03-05 | — | — | US | disclosed |
| US-20260043720-A1 | STABILIZED TWO-PART HEMATOXYLIN SOLUTION UTILIZING pH ADJUSTMENT | VENTANA MED SYST INC (US) | 2026-02-12 | — | — | US | disclosed |
| US-12474240-B2 | Stabilized two-part hematoxylin solution utilizing pH adjustment | VENTANA MEDICAL SYSTEMS, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| EP-4547291-A1 | LIGHT BEAM PROJECTION GUIDED BIOFABRICATION OF ALIGNED TISSUES | ETH Zurich (CH) | 2025-05-07 | — | — | EP | disclosed |
| EP-4305183-B1 | METHODS FOR DELIVERING A CARGO INTO A CELL | Trince bv (BE) | 2025-05-07 | — | — | EP | disclosed |
| CN-119789880-A | Biological manufacture of directional tissue guided by beam projection | 苏黎世联邦理工学院 | 2025-04-08 | — | — | CN | disclosed |
| US-20250108658-A1 | INKJET PRINTING PROCESSES FOR TEMPORARY TATTOOS | Prism Inks, Inc. (US) | 2025-04-03 | — | — | US | disclosed |
| EP-4501319-A1 | TABLET, PRINTED MATTER, AND PRINTING METHOD FOR EDIBLE INK | Toppan Holdings Inc. (JP) | 2025-02-05 | — | — | EP | disclosed |
| US-20250017863-A1 | TABLET, PRINTED MATTER, AND EDIBLE INK PRINTING METHOD | TOPPAN HOLDINGS INC. (JP) | 2025-01-16 | — | — | US | disclosed |
| US-20040179889-A1 | Liquid applicator for coloring a liquid | MEDI-FLEX HOSPITAL PRODUCTS, INC. | 2004-09-16 | — | — | US | disclosed |
| US-20040163968-A1 | Electrochemical production of dyes using graphite felt electrodes | EMERALD HILTON DAVIS, LLC | 2004-08-26 | — | — | US | disclosed |
| US-6729786-B1 | Liquid applicator for coloring a liquid | MEDIFLEX HOSPITAL PRODUCTS, INC. | 2004-05-04 | — | — | US | disclosed |
| US-6577884-B1 | Detection of stroke events using diffuse optical tomagraphy | THE GENERAL HOSPITAL CORPORATION | 2003-06-10 | — | — | US | disclosed |
| US-6516214-B1 | Detection of stroke events using diffuse optical tomography | THE GENERAL HOSPITAL CORPORATION | 2003-02-04 | — | — | US | disclosed |
| EP-1251771-A2 | DETECTION OF STROKE EVENTS USING DIFFUSE OPTICAL TOMOGRAPHY | THE GENERAL HOSPITAL CORPORATION (US) | 2002-10-30 | — | — | EP | disclosed |
| WO-2001052719-A2 | DETECTION OF STROKE EVENTS USING DIFFUSE OPTICAL TOMOGRAPHY | THE GENERAL HOSPITAL CORPORATION (US) | 2001-07-26 | — | — | WO | disclosed |
| US-5807604-A | SOLVENT MIXTURE COMPRISING TARTRAZINE YELLOW AND AQUEOUS ETHYLENE GLYCOL | PRESERVED BOTANICALS, INC. (US) | 1998-09-15 | — | — | US | disclosed |
| US-5693361-A | SOAKING NATURAL PLANT MATERIALS IN AQUEOUS SOLUTION CONTAINING ETHYLENE GLYCOL AND DISSOLVED CARBON DIOXIDE, FOR DECORATIONS | PRESERVED BOTANICALS, INC. (US) | 1997-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260063622-A1 | METHOD, SYSTEM, AND DEVICE FOR ANALYZING CELLULAR PROPERTIES WITH MACHINE LEARNING TO IDENTIFY STATES OF SENESCENCE | FN1, COL2A1, TFAM | THRB 1305/4885MEN1 3160/4885KMT2A 3323/4885 |
| US-20260043720-A1 | STABILIZED TWO-PART HEMATOXYLIN SOLUTION UTILIZING pH ADJUSTMENT | SMCHD1, KIT, CD68 | THRB 3803/4885MEN1 53/4885KMT2A 897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.